TNFRSF17 and Miyoshi myopathy: The MM cell lines KMS-12-PE and NCI-H929 expressed surface BCMA at 50 ± 4.2% (p < 0.0001) and 95.2 ± 3.1% (p < 0.0001), respectively, in contrast to K562 cells (Fig. 1A, B).